Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Beppu

Showing results (421-430 of 424) with videos related to

Pageof 43
Sort By:
You have reached the last page of results.This site can display upto 424 results.
British Journal of Cancer|July 1, 2015
miR-9-3p plays a tumour-suppressor role by targeting TAZ (WWTR1) in hepatocellular carcinoma cellsT Higashi, H Hayashi, T Ishimoto, et al.
Journal of Thrombosis and Haemostasis : JTH|August 21, 2010
High incidence of tumors in diabetic thrombin activatable fibrinolysis inhibitor and apolipoprotein E double-deficient miceT Beppu, P Gil-Bernabe, D Boveda-Ruiz, et al.
British Journal of Cancer|December 5, 2013
CD44s signals the acquisition of the mesenchymal phenotype required for anchorage-independent cell survival in hepatocellular carcinomaH Okabe, T Ishimoto, K Mima, et al.
BMC Cancer|May 7, 2017
Efficacy and safety of rebamipide liquid for chemoradiotherapy-induced oral mucositis in patients with head and neck cancer: a multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II studyT Yokota, T Ogawa, S Takahashi, et al.
Pageof 43

Showing results (421-430 of 424) with videos related to

Sort By:
Pageof 43
You have reached the last page of results.This site can display upto 424 results.
British Journal of Cancer|July 1, 2015
miR-9-3p plays a tumour-suppressor role by targeting TAZ (WWTR1) in hepatocellular carcinoma cellsT Higashi, H Hayashi, T Ishimoto, et al.
Journal of Thrombosis and Haemostasis : JTH|August 21, 2010
High incidence of tumors in diabetic thrombin activatable fibrinolysis inhibitor and apolipoprotein E double-deficient miceT Beppu, P Gil-Bernabe, D Boveda-Ruiz, et al.
British Journal of Cancer|December 5, 2013
CD44s signals the acquisition of the mesenchymal phenotype required for anchorage-independent cell survival in hepatocellular carcinomaH Okabe, T Ishimoto, K Mima, et al.
BMC Cancer|May 7, 2017
Efficacy and safety of rebamipide liquid for chemoradiotherapy-induced oral mucositis in patients with head and neck cancer: a multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II studyT Yokota, T Ogawa, S Takahashi, et al.
Pageof 43